Glenmark Pharmaceuticals Ltd.
Share Price Target & Analysis
NSE:GLENMARK
VWAP
Open
Close
High
Low
52 Week High
-39.50 (-1.6%)
GLENMARK
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Diamond
Valuation
#Analysis
NSE: GLENMARK Share Price Financial Analysis & Valuation
Glenmark Pharmaceuticals Ltd. (GLENMARK) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Large Cap company with Market Capitalization of Rs 13448.1 (in Cr). Total number of free float shares are 0 (in Lacs).
Glenmark Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE935A01035 and trading code is NSE:GLENMARK with short name Glenmark.
Glenmark Pharmaceuticals Ltd. is also traded in Future & Options (Derivative segment of NSE).
In the past 1 year, Glenmark Pharmaceuticals Ltd. has declared an equity dividend of Rs 0.21 per share. At the current share price of GLENMARK at Rs 2435.00, this results in a dividend yield of 0.01 %.
As per the Fundamental Analysis of NSE:GLENMARK, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLENMARK underlying value and future prospects. All of this data is available in GLENMARK financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:GLENMARK, it is clearly understood that GLENMARK is Economical performer in terms of earnings and profit margins with an EPS of 1.24. NSE:GLENMARK book value per share as of today is 881.78. The current price to book ratio for GLENMARK as of Sep 09, 2026 is 2.76.
Valuation of the Stock: The current valuation of GLENMARK stock is like Diamond which means currently the stock is Very Expensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLENMARK whether to BUY this stock at current valuation. The delivery percentage of GLENMARK is 219743% is very crucial parameter which shows that 219743% investors are anticipating that the price of GLENMARK share should go up with VWAP at 2443.5.
Now, the main question is whether to BUY or SELL, NSE:GLENMARK at current valuation.
As per latest Analysis No. #1846:-
⇑ STRONG BUY GLENMARK if All Greens
⇗ BUY GLENMARK (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD GLENMARK (With Stop Loss) if only 1 Green
⇘ SELL GLENMARK if NO Green Indicator
NSE: GLENMARK Share Price Today (Sep 09, 2026)
(Glenmark Pharmaceuticals Ltd. Daily Analysis on the basis of GLENMARK Intraday Graph & Trend)
Glenmark Pharmaceuticals Ltd. share price moved Down by -1.6% from its previous close of Rs 2474.5. GLENMARK stock last traded price is 2435.00. GLENMARK share price trend is Down with a total of 424450 stocks traded till now. It has touched an intraday high of Rs 2486.9 and an intraday low of Rs 2400.1. The GLENMARK trading at 2435.00, Down by Rs. -39.50, or -1.6 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down.
NSE: GLENMARK Share Price Tomorrow Prediction
(Glenmark Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLENMARK)
Glenmark Pharmaceuticals Ltd. share price moved Down by -1.6%. GLENMARK share price short term trend is Down. It suggests that GLENMARK Share Price for Tomorrow remains the same with VWAP at 2443.5 will be treated as stop loss for intraday traders. Glenmark Pharmaceuticals Ltd. Long term investors can follow the GLENMARK long term trend as mentiond in future forecast table.
NSE Code |
NSE: GLENMARK |
GLENMARK Share Price Today |
2435.00 |
GLENMARK Share Price Target Prediction for 2026 ^ |
2079.9 - 2550.2 |
GLENMARK Share Price Target Prediction for 2027*^ |
2550.2 - 2716.8 |
GLENMARK Share Price Target Prediction for 2028*^ |
2716.8 - 2907 |
GLENMARK Share Price Target Prediction for 2029*^ |
3052 |
GLENMARK Share Price Target Prediction for 2030*^ |
3140 |
GLENMARK Share Price Target Prediction for 2035*^ |
3422 |
| GLENMARK Current Book Value |
877.4 |
*Glenmark Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLENMARK share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
GLENMARK Technical Analysis
Candlestick Pattern: @2470.4| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 2472.74 | SELL | 2461.04 | BUY |
| MA_12 | 2384.93 | BUY | 2402.44 | BUY |
| MA_20 | 2347.47 | BUY | 2368.34 | BUY |
| MA_32 | 2296.24 | BUY | 2328.23 | BUY |
| MA_50 | 2275.19 | BUY | 2302.82 | BUY |
| MA_100 | 2277.24 | BUY | 2262.1 | BUY |
| MA_200 | 2146.67 | BUY | 2158.1 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 2347.47 | Uptrend |
| MACD | 16.73 | BUY |
| ADX | 22.44 | NO or Weak Trend |
| DMI (+/-) | 25.94 / 9.44 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 66.09 | Neutral |
| STOCHASTIC_K (Fast) | 58.52 | Neutral |
| STOCHASTIC_D (Slow) | 73.52 | Neutral |
| CCI | 93.24 | Neutral |
| PSAR | 2360.49 | BUY |
| TRUE RANGE | 39.9 | Neutral |
| ATR | 60.43 | Neutral |
| WILLIAMS R | -21.33 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 44.38 | Neutral |
| MOMENTUM | 240.4 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 26.64% |
| 3 Months | 12.23% |
| 1 Month | 10.78% |
| 1 Week | 2.93% |
| Action | Overall (%) |
|---|---|
| BUY | 60% |
| NEUTRAL / HOLD | 33% |
| SELL | 7% |
Most popular Questions & Answers about GLENMARK (/ FAQ GLENMARK)
Glenmark Pharmaceuticals Ltd. stock last traded price is 2435.00. GLENMARK share price moved Down by -1.6% from its previous close of Rs 2474.5.
Glenmark Pharmaceuticals Ltd. share price trend is Down with a total of 424450 stocks traded till now. It has touched an intraday high of Rs 2562.976 and an intraday low of Rs 2400.1. The GLENMARK trading at 2435.00, Down by Rs. -39.50, or -1.6 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down and the Stop Loss will be around 2443.5.
The market cap of Glenmark Pharmaceuticals Ltd. is ₹13448.1 (in Cr) as of Sep 08, 2026.
The current price to earning ratio for Glenmark Pharmaceuticals Ltd. as of Sep 08, 2026 is 335.86.
The current price to book ratio for Glenmark Pharmaceuticals Ltd. as of Sep 08, 2026 is 2.76.
The highest price of Glenmark Pharmaceuticals Ltd. stock is ₹2537.6 in the last 52-week.
The lowest price of Glenmark Pharmaceuticals Ltd. stock is ₹1792.6 in the last 52-week.
Glenmark Pharmaceuticals Ltd. share trading at ₹2435.00, Down by Rs. -39.50, or -1.6 percent which suggests that most of the traders are anticipating that the price of GLENMARK share should go Down.
In 2026, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2079.9 on downside and ₹2550.2 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.
In 2027, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2550.2 on downside and ₹2716.8 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2716.8 on downside and ₹2907 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹3140 Glenmark Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLENMARK.
The price of Glenmark Pharmaceuticals Ltd. (GLENMARK) shares moved by -1.6%. The short-term trend for GLENMARK share price is Down. It implies that the share price of GLENMARK will stay the same tomorrow and that intraday traders should treat VWAP at 2443.5 as a stop loss. Investors with a long-term outlook can track GLENMARK long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of GLENMARK stock is 14.9. Compared to the current market price of 2435.00 INR, the GLENMARK stock is Overvalued by 99.4%.
As per the fundamental analysis of Glenmark Pharmaceuticals Ltd. (GLENMARK), it is of Economical quality in terms of earnings and profit margins with an EPS of 1.24. Glenmark Pharmaceuticals Ltd. book value per share as of today is 881.78. The current price to book ratio for GLENMARK as of Sep 09, 2026 is 2.76.
NSE:GLENMARK News & Other Useful Information about GLENMARK Share Price
Peer Comparison of NSE: GLENMARK
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1864.90 | 16.35 | 97.89 |
| DIVISLAB | 9488.00 | 115.55 | 663.06 |
| MEDICAMEQ | 291.50 | 12.15 | 208.08 |
| CIPLA | 1363.10 | 51.67 | 434.03 |
| DRREDDY | 1145.00 | 53.19 | 380.63 |
| TORNTPHARM | 4930.00 | 87.32 | 235.7 |
| BIOCON | 395.00 | 1.27 | 166.51 |
| LUPIN | 2100.00 | 154.86 | 718.37 |
| ALKEM | 5139.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1698.90 | 46.49 | 403.84 |
| ABBOTINDIA | 25245.00 | 766.11 | 2448.41 |
| GLAXO | 2919.80 | 63.65 | 147.25 |
| IPCALAB | 1955.90 | 56.72 | 329.23 |
| LAURUSLABS | 1937.00 | 20.74 | 102.57 |
| LALPATHLAB | 1916.00 | 39.68 | 157.23 |
| PFIZER | 4173.50 | 170.54 | 963.41 |
| AJANTPHARM | 3534.40 | 89.3 | 363.23 |
| SANOFI | 3104.20 | 158.05 | 332.96 |
| NATCOPHARM | 826.30 | 82.14 | 481.67 |
| APLLTD | 817.40 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2435.00 | 1.24 | 881.78 |
| AAREYDRUGS | 98.01 | 2.39 | 53.38 |
| JUBLPHARMA | 1019.00 | 4.35 | 145.63 |
| SPARC | 200.58 | 48.14 | 40.45 |
| GRANULES | 884.80 | 23.25 | 180.42 |
| ASTRAZEN | 6876.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2723.10 | 55.52 | 285.6 |
| FDC | 354.30 | 21.19 | 161.21 |
| HIKAL | 240.69 | 9.34 | 96.63 |